USM Investing $250K in a Chemistry Alumna’s Product Designed to Heal Skin Wounds

Emily English portrait
Gemstone Biotherapeutics
CEO Emily English

The University System of Maryland (USM) recently invested $250,000 in Emily English’s (B.S. ’02, chemistry) biotech company called Gemstone Biotherapeutics. The company develops products for scar-free skin regeneration after dermatological surgeries.

The investment came through the system’s “Momentum Fund”—a $10 million fund established by the Board of Regents to provide funding for technology that comes out of any USM affiliate.

To continue reading this article, visit

Written by Carmen Molina Acosta for the Diamondback